Effective October 1, 2018, the Company amended its Articles of Incorporation to increase the number of authorized shares of Altra common stock from 90.0 million shares to 120.0 million shares. As of March 31, 2020 and December 31, 2019, there were 64,564,526 and 64,222,603 shares of common stock issued and outstanding, respectively.

On December 20, 2006, the Company amended and restated its certificate of incorporation authorizing 10.0 million shares of undesignated Preferred Stock (“Preferred Stock”). The Preferred Stock may be issued from time to time in one or more classes or series, the shares of each class or series to have such designations and powers, preferences, rights, qualifications, limitations and restrictions as determined by the Company’s Board of Directors. There was no Preferred Stock issued or outstanding at March 31, 2020 or December 31, 2019.

The 2014 Omnibus Incentive Plan (the “2014 Plan”) was approved by the Company’s stockholders at the Company’s 2014 Annual Meeting of Stockholders. The 2014 Plan provides for various forms of stock-based compensation to our directors, executive personnel and other key employees and consultants. Under the 2014 Plan, the remaining total number of shares of common stock available for delivery pursuant to the grant of awards (“Awards”) was 1.5 million as of March 31, 2020.

The restricted shares and restricted stock units issued pursuant to the 2014 Plan generally vest ratably over a period ranging from immediately to five years from the date of grant, provided, that the vesting of the restricted shares or restricted stock units may accelerate upon the occurrence of certain events. Common stock awarded under the 2014 Plan is generally subject to restrictions on transfer, repurchase rights, and other limitations and rights as set forth in the applicable award agreements. The fair value of the shares repurchased are measured based on the share price on the date of grant.

The 2014 Plan permits the Company to grant, among other things, restricted stock, restricted stock units, and performance share awards to key employees. Certain awards include vesting based upon achievement of specified performance criteria. Compensation expense recorded (in selling, general and administrative expense) during the quarters ended March 31, 2020 and 2019 was $3.3 million and $3.5 million, respectively. The Company recognizes stock-based compensation expense on a straight-line basis for the shares vesting ratably under the plan and uses the graded-vesting method of recognizing stock-based compensation expense for the performance share awards based on the probability of the specific performance metrics being achieved over the requisite service period.

The following tables set forth the activity of the Company’s restricted stock grants and stock options to date:

	Shares			Weighted- average fair value
Shares unvested January 1, 2020		786.3		$	35.69
Shares granted		322.0			34.58
Shares for which restrictions lapsed		(148.0	)		37.96
Shares unvested March 31, 2020		960.3		$	34.96

	Shares		Weighted- average fair value
Options unvested January 1, 2020		271.7	$	30.65
Options granted		214.5		34.78
Options exercised		—		—
Options outstanding March 31, 2020		486.2	$	32.47
Quantity ending exercisable balance		66.4	$	30.65

Total remaining unrecognized compensation cost is approximately $29.7 million as of March 31, 2020, and will be recognized over a weighted average remaining period of three years. The intrinsic value of these awards, as of March 31, 2020, was $16.8 million. Grant date fair value is based on the quoted price of the stock on the date of grant.